SML2225

RO5263397

≥98% (HPLC), TAAR1 agonist, powder

• Synonim(y): (S)-4-(3-Fluoro-2-methyl-phenyl)-4,5-dihydro-oxazol-2-ylamine
• Wzór empiryczny (zapis Hilla): C₁₀H₁₁FN₂O
• Numer CAS: 1357266-05-7
• Masa cząsteczkowa: 194.21
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD28405323
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Nazwa produktu: RO5263397, ≥98% (HPLC)
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]/D +77 to +88°, c = 1.0 in methanol
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: NC1=N[C@@H](C2=CC=CC(F)=C2C)CO1
• InChI: 1S/C10H11FN2O/c1-6-7(3-2-4-8(6)11)9-5-14-10(12)13-9/h2-4,9H,5H2,1H3,(H2,12,13)/t9-/m1/s1
• InChI key: IOHOUWIYOVWGHV-SECBINFHSA-N

Opis

Biochem/physiol Actions

Orally available, potent and selective partial TAAR1 agonist with similar in vivo efficacy as the full agonist RO5256390.

RO5256390 is an orally available partial agonist that targets trace amine-associated receptor 1 (TAAR1) with high affinity (Ki in nM = 0.9/mouse, 4.1/human, 9.1/rat, 24/monkey TARR1), potency (EC50 in nM/relative efficacy with respect to β-phenylethylamine = 1.3/0.59/mouse, 17/0.81/human, 47/0.76/rat, 251/0.85/monkey TARR1-dependent cellular cAMP production), and selectivity (by a 112-receptor/channel/transporter and a 42-enzyme panel), without agonistic activity toward mouse TAAR4-expressing cells even at a high concentration of 30 μM. When applied via oral administration (0.003-1 mg/kg), RO5256390 exhibits similar in vivo efficacy as the full agonist RO5256390 in blocking psychostimulants-induced hyperlocomotion in mice.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable